SCHEMBL6604801

SCHEMBL6604801

COC(=O)Nc1ccc(C(=O)N2CCCC(c3ccc4c(c3)OCO4)=N2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
POLB P06746 1/20 0.49
PGR P06401 7/20 0.49
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
MAPT P10636 4/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
RECQL P46063 1/20 0.47
GAA P10253 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
BCL2 P10415 1/20 0.46
BECN1 Q14457 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
CASP3 P42574 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144113 0.91 RAB9A (0.59) ALDH1A1POLBPGRNPC1RAB9A
SCHEMBL6603502 0.90 MAPT (0.56) ALDH1A1POLBPGRNPC1RAB9A
SCHEMBL6600744 0.85 AHR (0.61) ALDH1A1PGRNPC1RAB9AMAPT
SCHEMBL6602606 0.84 MAOB (0.55) ALDH1A1POLBPGRMAPTHPGD
SCHEMBL6606418 0.84 MAPT (0.50) ALDH1A1POLBPGRNPC1RAB9A
SCHEMBL7650542 0.84 ALDH1A1 (0.47) ALDH1A1POLBPGRMAPTPKM
SCHEMBL6600335 0.82 MAPT (0.48) ALDH1A1PGRNPC1RAB9AMAPT
SCHEMBL6602828 0.82 NPC1 (0.61) ALDH1A1PGRNPC1RAB9AMAPT
SCHEMBL6603267 0.82 MAPT (0.61) ALDH1A1PGRNPC1RAB9AMAPT
SCHEMBL6601189 0.82 PGR (0.56) ALDH1A1POLBPGRMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed